No relationship between inter- and intra-subject CV [Power / Sample Size]

posted by Helmut Homepage – Vienna, Austria, 2020-10-14 09:00 (185 d 15:28 ago) – Posting: # 21998
Views: 839

Hi arl_stat,

» Mostly in public domain, the inter subject CV of drug is not mentioned.

You fell into trap of wrong terminology. Even if a study was performed in a parallel design, one gets the total (a.k.a. pooled) CV – not the inter-subject CV.$$CV_{\textrm{total}}=\sqrt{\exp\left(\log_{e}(CV_{\textrm{inter}}^{2}+1)+\log_{e}(CV_{\textrm{intra}}^{2}+1)\right)-1}\tag{1}$$
Simply: The total variance (which you observe in any design) is the sum of inter- and intra-subject variances.$$s_{\textrm{total}}^{2}=s_{\textrm{inter}}^{2}+s_{\textrm{intra}}^{2}\tag{2}$$ The inter-subject CV is only accessible in a crossover study (see this post).

» […] can we use this intra-subject CV to estimate sample size for parallel study design?

No.

» Is there any formula to calculate inter-subject CV using 90% confidence interval ranges and number of subjects?

No, since you need the CVtotal calculated acc. to \((1)\) from a crossover – or directly observed in a parallel design – and there is no relationship between CVinter and CVintra. Hence, CVintra from a crossover alone does not help.
See also this post and followings.

» First can we calculate the sample size of 2 way crossover study design and then double the subjects and finalize the sample size for parallel study design?

No (see above). For ages rumors are swirling around a factor of two but that’s plain nonsense. Think about a drug with low CVintra and polymorphic metabolism. Then the factor can easily be >5 and by doubling the sample size of a crossover the parallel study will be grossly underpowered. BTW, in rare cases CVintra > CVinter.

Run a – not too small! – pilot study or a TSD.*



Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,511 registered users;
online 12 (0 registered, 12 guests [including 5 identified bots]).
Forum time: Sunday 00:28 UTC (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5